New York City-based NYU Langone Medical Center installed its third EOS system.
Spinal Tech
Intralink-Spine reports positive data from a safety and feasibility study on its Réjuve System for low back pain.
United Kingdom-based Invibio Biomaterial Solutions and China-based Double Medical Technology hosted an interbody spine surgery workshop, at the 10th Annual Congress of the Chinese Association of Orthopaedic Surgeons.
The introduction of new products leveraging platelet rich plasma and stem cell technology is driving the global orthobiologics market's growth.
DePuy Synthes, a Johnson & Johnson company, received a national contract from the U.S. Department of Defense for its orthopedic products.
Here are 18 key notes on orthopedic and spine device companies from the past week.
Regenerative medicine company Histogenics, based in Waltham, Mass., received a 2017 New England Innovation award sponsored by Waltham-based Smaller Business Association of New England.
Xtant Medical announced OrbiMed financing as well as an agreement with Aurora Management Partners.
Alphatec Holdings reported first quarter financial results.
Mazor Robotics struck a deal with Metronic last year, making the device industry giant the exclusive marketer for Mazor's newest iteration of its robotic spine surgery technology, Mazor X. Medtronic purchased 14 systems and the companies jointly sold 10 systems…
